AS
Andrew Sinclair
OtherActivePartner, Portfolio Manager at Abingworth
68
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Andrew Sinclair.
Investment Thesis & Strategy
Andrew Sinclair, as a Partner and Portfolio Manager at Abingworth, invests in various stages of biotech and pharmaceutical companies, seeking to support innovative ventures within the healthcare sector.
Portfolio Companies
Selected investments from their portfolio of 68 companies
V
VirionHealth
Biotech · Seed, 0
O
Oxagen
Other · , 0
S
SFJ Pharmaceuticals
Other · , 0
A
Avedro
Other · , 0
I
IFM Therapeutics
Other · , 0
V
Virion Biotherapeutics
Other · , 0
R
Realm Therapeutics
Other · , 0
P
Pixium Vision
Other · , 0
A
Algeta
Biotech · Series C+, 0
S
Sientra
Healthcare · Series B, 0
P
Pathwork Diagnostics
Healthcare · Series B, 0
S
Senseonics
Healthcare · Series C+, 0
Frequently Asked Questions
Andrew Sinclair focuses on Series B stage investments.